Cite
Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of...
MLA
Cabibbo, Giuseppe, et al. “Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian Practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association Of..” Digestive & Liver Disease, vol. 56, no. 3, Mar. 2024, pp. 394–405. EBSCOhost, https://doi.org/10.1016/j.dld.2023.10.028.
APA
Cabibbo, G., Daniele, B., Borzio, M., Casadei-Gardini, A., Cillo, U., Colli, A., Conforti, M., Dadduzio, V., Dionisi, F., Farinati, F., Gardini, I., Giannini, E. G., Golfieri, R., Guido, M., Mega, A., Cinquini, M., Piscaglia, F., Rimassa, L., Romanini, L., & Pecorelli, A. (2024). Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of.. Digestive & Liver Disease, 56(3), 394–405. https://doi.org/10.1016/j.dld.2023.10.028
Chicago
Cabibbo, Giuseppe, Bruno Daniele, Mauro Borzio, Andrea Casadei-Gardini, Umberto Cillo, Agostino Colli, Massimiliano Conforti, et al. 2024. “Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian Practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association Of..” Digestive & Liver Disease 56 (3): 394–405. doi:10.1016/j.dld.2023.10.028.